Dr. Guanhu Yang | Acupuncture | Research Excellence Award

Posted on by sciencefather

Dr. Guanhu Yang | Acupuncture | Research Excellence Award

Dr. Guanhu Yang, Ohio University, United States

Dr. Guanhu Yang, MD, PhD, LAc, is a distinguished figure in Traditional Chinese Medicine (TCM) with extensive experience spanning over three decades in both clinical practice and academia. Based in Mason, Ohio, he holds a PhD from Kanazawa Medical University in Japan, focusing on lung injury and repair. He also earned an MS from Nanjing University of Chinese Medicine and a medical degree from Zhejiang Chinese Medical University. Dr. Yang serves as a professor and doctoral supervisor and holds editorial roles in international medical journals. As the President of the Chinese Medicine Luobing Society of America and an executive leader in numerous TCM associations globally, Dr. Yang is dedicated to advancing integrative medicine. His clinical expertise and research contributions in TCM, particularly in acupuncture and herbology, continue to shape modern understanding of holistic healthcare.

Professional Profile

google scholar

Summary of Suitability for the Research for Research Excellence Award

Dr. Guanhu Yang, with his MD and PhD background in Traditional Chinese Medicine (TCM) and a substantial focus on lung injury and repair, presents a commendable profile for the “Research for Research Excellence Award.” His career spans more than three decades across multiple countries, including China, Japan, Canada, Switzerland, and the United States, where he has contributed as a clinician, academician, researcher, and leader. Dr. Yang has held diverse positions, such as a Clinical Professor, Editor, and President of TCM societies, and he actively shapes global standards in acupuncture and TCM practices. His experience extends to editing roles in prominent scientific journals, further demonstrating his impact on academic and clinical research communities. Moreover, his leadership in major TCM organizations and contribution to Chinese medicine education worldwide underscores his dedication to advancing medical science.

🎓    Education

Dr. Yang’s academic journey began at Zhejiang Chinese Medical University, where he earned his MD in Traditional Chinese Medicine. He furthered his studies at Nanjing University of Chinese Medicine, completing a master’s degree in Medical Science. His dedication to medical research led him to Kanazawa Medical University in Japan, where he earned a PhD focusing on lung injury and repair. Through his academic progression, Dr. Yang gained a strong foundation in traditional and modern medicine, enabling a profound understanding of integrative health practices. His extensive licensure includes certifications in Acupuncture and Oriental Medicine by the State Medical Board of Ohio, and he holds a Diplomate in both Acupuncture and Chinese Herbology from the NCCAOM, solidifying his credentials in Traditional Chinese Medicine and allowing him to practice and teach extensively across continents.

💼  Experience

Dr. Yang has held numerous positions worldwide, including Professor and Doctoral Supervisor at Macau University of Science and Technology and Clinical Professor at Ohio University. He serves as a guest editor for multiple scientific journals and holds visiting professor roles in Canada and the United States. He has worked extensively with global organizations such as the World Federation of Chinese Medicine Societies, serving as Vice Chairman on committees for both Endocrine and Digestion research. As the Chief Acupuncturist and owner of Acupuncture Wellness Center of Cincinnati and Mason, Dr. Yang combines his clinical expertise with research initiatives, significantly impacting both patient care and academic communities.

🏅  Awards and Honors

Dr. Yang’s dedication to Traditional Chinese Medicine has earned him numerous accolades, including the title of Distinguished Clinical Expert by the Swiss University of Traditional Chinese Medicine. He has been recognized for his editorial contributions as Associate Editor for leading journals, including the New England Journal of Traditional Chinese Medicine. His influence extends to various TCM associations, serving as Vice President of the American TCM Association and American Association of Chinese Herbs. Dr. Yang’s contributions to integrative medicine and his role as an academic advisor to international institutes underscore his impact and dedication to advancing Traditional Chinese Medicine.

🌍  Research Focus

Dr. Yang’s research integrates Traditional Chinese Medicine with modern medical sciences, focusing on the effects of acupuncture and herbal medicine on chronic diseases, including lung injury, endocrinology, and internal medicine. His studies in gene therapy and cancer drug targeting have led to numerous publications in high-impact journals. He is particularly interested in the dose-response relationship within herbal prescriptions, aiming to enhance the efficacy of TCM treatments. As a research scientist and clinical professor, Dr. Yang continues to advance therapeutic interventions that bridge Eastern and Western practices, fostering a holistic approach to healthcare.

📖 Publication Top Notes

  • Title: The transcription factor gene Nfib is essential for both lung maturation and brain development

    Cited by: 349

  • Title: Atractylenolide III ameliorates cerebral ischemic injury and neuroinflammation associated with inhibiting JAK2/STAT3/Drp1-dependent mitochondrial fission in microglia

    Cited by: 121

  • Title: The most commonly treated acupuncture indications in the United States: a cross-sectional study

    Cited by: 102

  • Title: Nuclear factor I/thyroid transcription factor 1 interactions modulate surfactant protein C transcription

    Cited by: 81

  • Title: Schaftoside ameliorates oxygen glucose deprivation-induced inflammation associated with the TLR4/Myd88/Drp1-related mitochondrial fission in BV2 microglia cells

    Cited by: 67

Prof. Yankuo Qiao | Finance | Best Researcher Award

Posted on by sciencefather

Prof. Yankuo Qiao | Finance | Best Researcher Award

Prof. Yankuo Qiao, The George B. Delaplaine Jr. School of Business, Hood College, United States

Yankuo Qiao is an Assistant Professor of Finance at Hood College’s George B. Delaplaine Jr. School of Business, where he began in August 2022. Prior to this, he held the position of Visiting Assistant Professor of Finance at Oakland University. His academic journey is marked by a strong focus on finance, having completed a Ph.D. in Management from Rutgers Business School, specializing in Finance and Economics. His research interests span corporate finance, governance, behavioral finance, and corporate social responsibility, among others. Dr. Qiao’s work has been presented at numerous prestigious conferences globally, such as the American Finance Association and the Western Economic Association. With a passion for teaching and mentoring, he imparts knowledge across various finance and management disciplines. His academic achievements and contributions continue to shape the next generation of business leaders while advancing research in finance.

Professional Profile

scopus

orcid

google scholar

Summary of Suitability for the Research for Best Researcher Award

Dr. Yankuo Qiao is a highly qualified candidate for the Research for Best Researcher Award. With a Ph.D. in Management from Rutgers Business School, Dr. Qiao has made notable contributions in finance and economics, particularly in corporate finance, governance, and corporate social responsibility. His academic journey is marked by a Dean’s Dissertation Fellowship, which reflects his scholarly excellence.

🎓  Education 

Yankuo Qiao holds a Ph.D. in Management with a focus on Finance and Economics from Rutgers Business School, completed in May 2021. His dissertation, “Three Essays in Corporate Management and Firm Policy,” reflects his deep expertise in corporate finance, with a committee chaired by renowned professors Ivan Brick, Darius Palia, and others. His academic journey began with a B.Sc. in Economics from the School of Business, Shandong University in May 2014. He later pursued an M.Sc. in Quantitative Finance from Rutgers Business School, graduating in May 2016, further enhancing his skills in financial analysis, corporate governance, and investment strategies. His education, combined with his research, has given him a solid foundation for his teaching and professional career, particularly in areas such as corporate governance, behavioral finance, and international business.

💼  Experience

Dr. Yankuo Qiao is currently serving as an Assistant Professor of Finance at Hood College, where he has been since August 2022. He previously held the role of Visiting Assistant Professor of Finance at Oakland University from August 2021 to July 2022. During his academic tenure, he has taught various finance and business-related courses, including Managerial Finance, Corporate Finance, and International Business, at both undergraduate and graduate levels. His expertise extends beyond teaching, as he is also actively involved in academic research and publishing, with a particular focus on corporate governance, corporate social responsibility, and behavioral finance. His teaching experience spans esteemed institutions like Rutgers Business School, where he served as a primary instructor for advanced finance courses. Dr. Qiao’s experience also includes organizing workshops, contributing to curriculum development, and mentoring students in research methodologies.

🏅  Awards and Honors

Throughout his academic career, Dr. Yankuo Qiao has garnered several accolades that reflect his dedication to excellence. Notably, he was awarded the prestigious Dean’s Dissertation Fellowship for Academic Excellence at Rutgers Business School during his Ph.D. studies. His dissertation work, recognized for its insightful contributions to corporate finance and firm policy, earned him further acclaim in his field. Additionally, Dr. Qiao’s research has been featured in top-tier conferences, such as the American Finance Association (AFA) Annual Meeting and the Financial Management Association Annual Meeting. His paper presentations have been well-received at notable venues like the Western Economic Association International, where his innovative research on corporate governance and behavioral finance continues to influence academia. He has also been invited to numerous seminars and conferences worldwide, showcasing his expertise and dedication to advancing financial research.

🌍 Research Focus 

Dr. Yankuo Qiao’s research primarily revolves around corporate finance, governance, and social responsibility, with a keen interest in understanding how corporate decision-making affects firm performance. He explores the dynamics of corporate governance, particularly in how internal and external mechanisms influence a CEO’s investment cycle and decision-making. His research also delves into behavioral finance, examining the psychological factors that affect financial decisions, and corporate social responsibility, exploring its impact on firm value and sustainability. Additionally, Dr. Qiao applies machine learning techniques to financial analysis, investigating the implications of textual data in finance and accounting. His current projects include studies on hate crimes’ impact on analyst behaviors, CEO career experiences in China, and the nexus of top management teams’ structures with stock liquidity and valuation. His forward-looking research is presented at global conferences, contributing significantly to the fields of finance and governance.

 📖 Publuaction Top Notes

  • The Application in the Portfolio of China’s A-share Market with Fama-French Five-Factor Model and the Robust Median Covariance Matrix
    • Citation: 9
  • Impact of Internal Governance on a CEO’s Investment Cycle
    • Citation: 6
  • The impact of external business environment on corporate social responsibility: Theoretical implications and empirical evidence
    • Citation: 3
  • CEO turnover, stakeholder management, and dynamics between corporate social responsibility and firm performance
    • Citation: 2
  • Attunement theory, CEO’s cyclical influence on corporate social responsibility and firm value
    • Citation: 2

Dr. MENGYING YAN | biomaterial | Women Researcher Award

Posted on by sciencefather

Dr. MENGYING YAN | biomaterial | Women Researcher Award

Dr. MENGYING YAN, The Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, China

Mengying Yan is an accomplished researcher specializing in neural interface materials, bio-3D printing, and cell culture technology. She holds a Ph.D. in Pharmaceutical, Food, and Cosmetic Sciences from the University of Genoa, Italy, and has extensive experience in food science and nutrition. Mengying’s career spans over five years in academic and research environments, primarily at the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. She has worked as an assistant researcher and postdoctoral fellow, focusing on cutting-edge materials for neural interfaces and flexible electronic materials. Fluent in Italian and English, Mengying’s linguistic and cross-cultural communication skills have been honed by her nine years of international experience. Her research contributions have led to numerous publications in high-impact journals, showcasing her expertise in materials science and bioengineering. Mengying also has a passion for art, particularly traditional Chinese painting, and enjoys integrating creativity into her scientific endeavors.

Professional Profile

Orcid

Summary of Suitability for the Research for Women Researcher Award

Mengying Yan is a highly qualified candidate for the Research for Women Researcher Award. With over 10 years of academic and research experience in the fields of pharmaceutical, food, and cosmetic sciences, her expertise spans across cell culture, 3D printing, neural interface materials, and conductive polymers. She holds a Ph.D. from the University of Genoa, Italy, and has contributed to advanced research during her time as a postdoctoral researcher and assistant researcher at the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences. Her research has resulted in several high-impact publications, and she has been recognized as a co-first author in notable journals like Advanced Healthcare Materials and ACS Applied Materials & Interfaces.

🎓   Education 

Mengying Yan’s academic journey reflects a deep commitment to science and research. She earned her Ph.D. in Pharmaceutical, Food, and Cosmetic Sciences from the University of Genoa, Italy, in 2018. During her doctoral studies, she focused on hydrogels for 3D cell culture, further expanding her expertise with an internship at the EU Institute on Membrane Technology (ITM-CNR), where she worked on developing drug-loaded microspheres using membrane emulsification techniques. Prior to this, Mengying completed her Master’s degree in Nutrition from the University of Calabria, Italy, and a Bachelor’s degree in Food Science and Engineering from Sichuan University, China. Her education equipped her with a comprehensive understanding of food science, membrane technology, and cellular systems. This strong foundation has been crucial in her current research work on neural interfaces and flexible materials, driving innovation and advancing the boundaries of biomedical technology.

💼   Experience 

Mengying Yan’s professional experience spans diverse areas of materials science and biomedical research. Currently, she serves as an Assistant Researcher at the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, where she focuses on 3D cell culture systems, flexible electronic materials, and neural interface technologies. Previously, she completed a postdoctoral fellowship at the same institution, contributing to significant advancements in bio-3D printing and conductive ink development. Her responsibilities included daily laboratory management, training new employees, and overseeing the maintenance of sophisticated research equipment. Mengying’s hands-on expertise with instruments such as UV spectrophotometers, DSC, and electrochemical workstations has enabled her to excel in experimental research. Her extensive academic background and practical experience, combined with her organizational skills and technical proficiency, make her a well-rounded researcher with the ability to lead innovative projects in biomedical engineering.

🏅   Awards and Honors 

Mengying Yan’s academic and research excellence has been recognized through multiple awards and honors. During her doctoral studies at the University of Genoa, she received a prestigious research grant from the European Union’s Institute on Membrane Technology (ITM-CNR), which funded her innovative work on developing drug-loaded microspheres for therapeutic applications. Her contributions to neural interface technology and bio-3D printing have garnered attention in the scientific community, resulting in her being selected as a co-author in several high-impact publications. In addition to academic recognition, Mengying has been honored for her mentorship and leadership in guiding new researchers at the Shenzhen Institutes of Advanced Technology. Her proficiency in integrating advanced scientific techniques with practical applications has set her apart as a leader in her field, earning her accolades from both peers and institutions. Mengying’s achievements are a testament to her dedication, innovation, and contributions to biomedical research.

🌍   Research Focus 

Mengying Yan’s research focuses on the intersection of materials science and biomedical engineering, with a particular emphasis on neural interface technologies and 3D cell culture systems. She has made significant contributions to developing flexible electronic materials and conducting polymers that improve the electrode-neural interface, facilitating better communication between electronic devices and biological tissues. Mengying’s work also explores bio-3D printing and the creation of hydrogel scaffolds that mimic natural tissue environments, enabling more effective tissue engineering and regenerative medicine. Her research aims to solve critical challenges in neural interface systems, enhancing their integration with the human body for medical applications such as brain-computer interfaces. By combining materials innovation with biological applications, Mengying’s research holds promise for advancing treatments for neurodegenerative diseases and improving prosthetic technologies. Her interdisciplinary approach ensures her research stays at the forefront of biomedical advancements.

 📖 Publications Top Notes

  • Three-dimensional highly porous hydrogel scaffold for neural circuit dissection and modulation
  • Flexible and stretchable polymer optical fibers for chronic brain and vagus nerve optogenetic stimulations in free-behaving animals
  • Low‐Cost Paper‐Based Conducting Polymer‐Hydrogel Flexible Bio‐Radar Sensor for Detecting Biological Objects
  • Development of enzyme-loaded PVA microspheres by membrane emulsification
    Development and characterization of a mucoadhesive sublingual formulation for pain control: Extemporaneous oxycodone films in personalized therapy

     

Dr. Stela Dragomanova | Neuroscience | Best Researcher Award

Posted on by sciencefather

Dr. Stela Dragomanova| Neuroscience | Best Researcher Award

Dr. Stela Dragomanova, Medical University of Varna, Bulgaria

Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.

Professional Profile

Orcid

Summary of Suitability for the Research for Best Researcher Award

Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.

🎓 Education 

Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.

💼 Experience 

Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.

🏅Awards and Honors 

Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.

🌍 Research Focus 

Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.

📖 Publications Top Notes

  • Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
  • Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
  • Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
  • Neuropharmacological investigation of myrtenal conjugates with aminoadamantane
  • Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2